Inhibition Of LSD1 As a Therapeutic Strategy For The Treatment Of Acute Myeloid Leukemia
Ryan G. Kruger(Arysta LifeScience (France)), Peter J. Tummino(Intarcia Therapeutics (United States)), Scott A. Armstrong(Courant Institute of Mathematical Sciences), Charles F. McHugh(GlaxoSmithKline (United States)), Dominic Suarez(GlaxoSmithKline (United States)), Meagan B. Rouse(GlaxoSmithKline (United States)), Monica Cusan(Memorial Sloan Kettering Cancer Center), Xinrong Tian(GlaxoSmithKline (United Kingdom)), Melissa B. Pappalardi(GlaxoSmithKline (United States)), Thau Ho(GlaxoSmithKline (United States)), Jiri Kasparec(GlaxoSmithKline (United States)), Kimberly N. Smitheman(GlaxoSmithKline (United States)), Kelly Federowicz(GlaxoSmithKline (United States)), Neil W. Johnson(Brandywine Photonics (United States)), Yan Liu(Qingdao University), William H. Miller(Clinical Innovations (United States)), Glenn Van Aller(GlaxoSmithKline (United States)), Jessica L. Schneck(GlaxoSmithKline (United States)), Patrick McDevitt(GlaxoSmithKline (United States)), Helai P. Mohammad(Arysta LifeScience (France)), Jeffrey D. Carson(GlaxoSmithKline (United States))
Cited by 30
Related Papers
The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease
|Science|2006|5.5k
Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori
|Nature|1999|1.9k
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
|Nature|2012|1.8k
Hydrolysis of Biological Peptides by Human Angiotensin-converting Enzyme-related Carboxypeptidase
|Journal of Biological Chemistry|2002|1.4k
The promise and peril of chemical probes
|Nature Chemical Biology|2015|848